Glycogen synthase kinase-3 is activated in neuronal cells by Gα12 and Gα13 by Rho-independent and Rho-dependent mechanisms

Journal of Neuroscience

Volumn 22, Issue 16, 2002, Pages 6863-6875

  Sayas, C Laura ^a   Avila, Jesús ^a   Wandosell, Francisco ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

GSK 3 activation; G 12 13; Lysophosphatidic acid; Neurite retraction; RhoA; Tau hyperphosphorylation

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; LITHIUM; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE C; RHO FACTOR; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; GRANULE CELL; MOUSE; NERVE CELL; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0037104720     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-16-06863.2002     Document Type: Article

References (57)

1. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97:11074-11079.
2. Contos JJ, Chun J (2001) The mouse 1p(A3)/Edg7 lysophosphatidic acid receptor gene: Genomic structure, chromosomal localization, and expression pattern. Gene 267:243-253.
3. Contos JJ, Ishii I, Chun J (2000) Lysophosphatidic acid receptors. Mol Pharmacol 58:1188-1196.
4. Cook D, Fry MJ, Hughes K, Sumathipala R, Woodgett JR, Dale TC (1996) Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a PKC. EMBO J 15:4526-4536.
5. Cross D (2001) Assays for glycogen synthase kinase-3 (GSK-3). Methods Mol Biol 124:147-159.
6. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
7. Crowder RJ, Freeman RS (2000) Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275:34266-34271.
8. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95:11211-11216.
9. Djellas Y, Manganello JM, Antonakis K, Le Breton GC (1999) Identification of Gα13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors. J Biol Chem 274:14325-14330.
10. Fang X, Yu SX, Lu Y, Bast Jr RC, Woodgett JR, Mills GB (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960-11965.
11. Ferkey DM, Kimelman D (2000) GSK-3: New thoughts on an old enzyme. Dev Biol 225:471-479.
12. Fukushima N, Weiner JA, Chun J (2000) Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev Biol 228:6-18.
13. Goedert M (1993) tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16:460-465.
14. Gohla A, Harhammer R, Schultz G (1998) The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J Biol Chem 273:4653-4659.
15. Gohla A, Offermanns S, Wilkie TM, Schultz G (1999) Differential involvement of Gα12 and Gα13 in receptor-mediated stress fiber formation. J Biol Chem 274:17901-17907.
16. Goold RG, Owen R, Gordon-Weeks PR (1999) Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J Cell Sci 112:3373-3384.
17. Hall AC, Lucas FR, Salinas PC (2000) Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100:525-535.
18. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147:58-62.
19. Hartigan JA, Johnson GV (1999) Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem 274:21395-21401.
20. Hartigan JA, Xiong WC, Johnson GV (2001) Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochem Biophys Res Commun 284:485-489.
21. Hecht JH, Weiner JA, Post SR, Chun J (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135:1071-1083.
22. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12:803-808.
23. Jalink K, Eichholtz T, Postma FR, van Corven EJ, Moolenaar WH (1993) Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action. Cell Growth Differ 4:247-255.
24. Katoh H, Aoki J, Yamaguchi Y, Kitano Y, Ichikawa A, Negishi M (1998) Constitutively active Gα12, Gα13, and Gαq induce Rho-dependent neurite retraction through different signaling pathways. J Biol Chem 273:28700-28707.
25. Kim L, Liu J, Kimmel AR (1999) The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99:399-408.
26. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459.
27. Kranenburg O, Poland M, van Horck FP, Drechsel D, Hall A, Moolenaar WH (1999) Activation of RhoA by lysophosphatidic acid and Gα12/13 subunits in neuronal cells: Induction of neurite retraction. Mol Biol Cell 10:1851-1857.
28. Lesort M, Jope RS, Johnson G V (1999) Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72:576-584.
29. Levi G, Aloisi F, Ciotti MT, Thangnipon W (1989) Preparation of 98% pure cerebellar granule cell cultures. In: A Dissection and Tissue Culture Manual of the Nervous System (Shahar A, de Vellis J, Vernadakis A, Harber B, eds), pp 211-214. New York: Liss.
30. Lucas FR, Goold RG, Gordon-Weeks PR, Salinas PC (1998) Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J Cell Sci 111:1351-1361.
31. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20:27-39.
32. Mandelkow EM, Biernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E (1995) Tau domains, phosphorylation, and interactions with microtubules. SAAS Bull Biochem Biotechnol 16:355-362.
33. Mao J, Xie W, Yuan H, Simon MI, Mano H, Wu D (1998) Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Gα12/13. EMBO J 17:5638-5646.
34. Moolenaar WH (1999) Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253:230-238.
35. Needham LK, Rozengurt E (1998) Gα12 and Gα13 stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130 Crk-associated substrate. J Biol Chem 273:14626-14632.
36. Onorato M, Mulvihill P, Connolly J, Galloway P, Whitehouse P, Perry G (1989) Alteration of neuritic cytoarchitecture in Alzheimer's disease. Prog Clin Biol Res 317:781-789.
37. Paudel HK, Lew J, Ali Z, Wang JH (1993) Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 268:23512-23518.
38. Postma FR, Jalink K, Hengeveld T, Moolenaar WH (1996) Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: Action through a specific cell surface receptor. EMBO J 15:2388-2392.
39. Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, Cohen P (1980) Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur J Biochem 107:529-537.
40. Saito S (1997) Effects of lysophosphatidic acid on primary cultured chick neurons. Neurosci Lett 229:73-76.
41. Salinas PC (1999) Wnt factors in axonal remodelling and synaptogenesis. Biochem Soc Symp 65:101-109.
42. Sanchez C, Perez M, Avila J (2000) GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. Eur J Cell Biol 79:252-260.
43. Sayas CL, Moreno-Flores MT, Avila J, Wandosell F (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like tau phosphorylation. J Biol Chem 274:37046-37052.
44. Shi CS, Sinnarajah S, Cho H, Kozasa T, Kehrl JH (2000) G13α-mediated PYK2 activation. PYK2 is a mediator of G13α-induced serum response element-dependent transcription. J Biol Chem 275:24470-24476.
45. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC (1996) Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17:1201-1207.
46. Sperber BR, Leight S, Goedert M, Lee VM (1995) Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 197:149-153.
47. Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664-1668.
48. Steiner MR, Holtsberg FW, Keller JN, Mattson MP, Steiner SM (2000) Lysophosphatidic acid induction of neuronal apoptosis and necrosis. Ann NY Acad Sci 905:132-141.
49. Suidan HS, Stone SR, Hemmings BA, Monard D (1992) Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8:363-375.
50. Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, Imahori K (1994) Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem 63:245-255.
51. 2+ signaling and Rho. J Neurochem 66:537-548.
52. Wadsworth SJ, Gebauer G, van Rossum GD, Dhanasekaran N (1997) Ras-dependent signaling by the GTPase-deficient mutant of Gα12. J Biol Chem 272:28829-28832.
53. Welsh GI, Proud CG (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294:625-629.
54. Welsh GI, Patel JC, Proud CG (1997) Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts. Anal Biochem 244:16-21.
55. Windh RT, Lee MJ, Hla T, An S, Barr AJ, Manning DR (1999) Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem 274:27351-27358.
56. Wischik CM, Crowther RA, Stewart M, Roth M (1985) Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol 100:1905-1912.
57. Woodgett JR, Plyte SE, Pulverer BJ, Mitchell JA, Hughes K (1993) Roles of glycogen synthase kinase-3 in signal transduction. Biochem Soc Trans 21:905-907.